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CONCENTRATION-DEPENDENT VASCULAR EFFECTS OF DIVALENT 
MANGANESE 
CMS Detremmerie, SWS Leung, PM Vanhoutte 
 
State Key Laboratory for Pharmaceutical Biotechnology and Department of Pharmacology and 
Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 
 
OBJECTIVES: Divalent manganese is a cofactor for soluble guanylyl cyclase (sGC), the enzyme 
producing cyclic GMP in vascular smooth muscle cells that causes relaxation. Manganese 
competes with magnesium to activate sGC. These divalent cations can bias the activity of the 
enzyme to produce cyclic nucleotides other than cyclic GMP, in particular cyclic AMP and cyclic 
IMP. Cyclic IMP, preferably produced in the presence of magnesium, can cause contraction in 
precontracted arteries of the pig. The objective of the present study was to identify the 
mechanisms by which manganese, compared to magnesium [used in standard physiological 
solutions at millimolar concentrations for functional studies], affects endothelium-dependent and 
-independent relaxations by influencing intracellular levels of cyclic nucleotides. 
 
METHODS: Ex vivo experiments were designed using isolated rat aortae of Sprague-Dawley rats 
of 12-14 weeks of age and porcine coronary arteries (collected at the local abattoir). The arteries 
were cut into rings and used for measurement of vascular reactivity in conventional organ 
chambers using pharmacological inhibitors of endothelial nitric oxide (NO) synthase (LNAME) 
and of cyclooxygenases (indomethacin). In some rings, the endothelium was removed through 
insertion of a wooden toothpick. After obtaining an optimal resting tension, the rings were treated 
with millimolar concentrations of manganese or magnesium for fortyfive minutes and 
precontracted with phenylephrine (rat aortae) or U46619 (porcine coronary arteries). 
Subsequently, concentration-dependent responses were obtained with acetylcholine (rat arteries), 
bradykinin (porcine coronary arteries) and the NO-donor SNP. In parallel, in vitro experiments 
were conducted using cultured porcine coronary artery smooth muscle cells (PCASMCs). The 
cells were exposed to millimolar concentrations of manganese or magnesium in the presence or 
absence of a sGC-activator (YC-1). Intracellular cyclic GMP levels were measured using a 
commercially available ELISA kit. RESULTS: In vivo, millimolar ranges of manganese 
significantly decreased endothelium-dependent relaxations to acetylcholine in rat aortae and to 
bradykinin in porcine coronary arteries compared to physiological levels of magnesium. This 
effect was abolished by endothelium-removal. In addition, L-NAME partially reversed the effect 
of manganese, while indomethacin did not. Manganese also decreased, but to a smaller extent, 
endotheliumindependent relaxations to SNP in both porcine coronary arteries and rat aortae. In 
parallel, the in vitro study showed that manganese alone or in combination with YC-1 blocks the 
production of cyclic GMP. 
 
CONCLUSIONS: Taken into conjunction, these experiments show that manganese at millimolar 
levels decreases endothelium-dependent and –independent relaxations compared to physiological 
levels of magnesium. This is likely explained through a decrease in cyclic GMP production. The 
effect of manganese is endothelium-dependent. In the case of endothelium-dependent relaxations 
(to acetylcholine or bradykinin), the effect of manganese is mediated by endothelial NO synthase, 
but not by cyclooxygenases. These findings indicate that in the presence of manganese NO does 
not act as a vasodilator and must lead to production of cyclic nucleotides other than cyclic GMP 
to cause contraction, similar to what has been reported under hypoxic conditions. 
